TREM2 and Cognitive impairment: Clinically, elevated levels of soluble TREM2 (sTREM2) in cerebrospinal fluid are associated with attenuated cognitive decline and reduced neurodegenerative risk, particularly among APOE ε4 carriers at the mild cognitive impairment (MCI) stage [124].